Celvive, Inc. is a biotechnology company being spun out of UMDNJ-CINJ utilizing technology for the preparation of intrathecal administration of bone-marrow derived stem cells for neural regeneration in those incurring spinal cord injuries (SCI) from such events as motor vehicle accidents, falls, sports related injuries, and violence.